Literature DB >> 24719900

Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?

Mohammad Bashashati, Reza A Hejazi, Christopher N Andrews, Martin A Storr.   

Abstract

Gastroesophageal reflux (GER) is a common gastrointestinal process that can generate symptoms of heartburn and chest pain. Proton pump inhibitors (PPIs) are the gold standard for the treatment of GER; however, a substantial group of GER patients fail to respond to PPIs. In the past, it was believed that acid reflux into the esophagus causes all, or at least the majority, of symptoms attributed to GER, with both erosive esophagitis and nonerosive outcomes. However, with modern testing techniques it has been shown that, in addition to acid reflux, the reflux of nonacid gastric and duodenal contents into the esophagus may also induce GER symptoms. It remains unknown how weakly acidic or alkaline refluxate with a pH similar to a normal diet induces GER symptoms. Esophageal hypersensitivity or functional dyspepsia with superimposed heartburn may be other mechanisms of symptom generation, often completely unrelated to GER. Detailed studies investigating the pathophysiology of esophageal hypersensitivity are not conclusive, and definitions of the various disease states may overlap and are often confusing. The authors aim to clarify the pathophysiology, definition, diagnostic techniques and medical treatment of patients with heartburn symptoms who fail PPI therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24719900      PMCID: PMC4072238          DOI: 10.1155/2014/904707

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


  83 in total

1.  Lack of association between esophageal acid sensitivity detected by prolonged pH monitoring and Bernstein testing.

Authors:  Barbara Jung; Joseph Steinbach; Cheryl Beaumont; Ravinder K Mittal
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

Review 2.  Therapeutic options for refractory gastroesophageal reflux disease.

Authors:  Ronnie Fass
Journal:  J Gastroenterol Hepatol       Date:  2012-04       Impact factor: 4.029

3.  Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure.

Authors:  Renato Caviglia; Mentore Ribolsi; Nicola Maggiano; Armando M Gabbrielli; Sara Emerenziani; Michele Pier Luca Guarino; Simone Carotti; Fortunéé Irene Habib; Carla Rabitti; Michele Cicala
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

Review 4.  Effects of proton pump inhibitors on gastric emptying: a systematic review.

Authors:  Masaki Sanaka; Takatsugu Yamamoto; Yasushi Kuyama
Journal:  Dig Dis Sci       Date:  2009-12-10       Impact factor: 3.199

Review 5.  Update on the pharmacogenomics of proton pump inhibitors.

Authors:  Krisztina Hagymási; Katalin Müllner; László Herszényi; Zsolt Tulassay
Journal:  Pharmacogenomics       Date:  2011-06       Impact factor: 2.533

6.  Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.

Authors:  Michael Shapiro; Colleen Green; Jimmy M Bautista; Raniero L Peru; Isaac B Malagon; Matthew Corvo; Sara Risner-Adler; Joy N Beeler; Irina Tuchinsky; Ronnie Fass
Journal:  Am J Gastroenterol       Date:  2006-05       Impact factor: 10.864

Review 7.  New techniques to evaluate esophageal function.

Authors:  Daniel Sifrim; Kathleen Blondeau
Journal:  Dig Dis       Date:  2006       Impact factor: 2.404

Review 8.  Do endoscopic antireflux procedures fit in the current treatment paradigm of gastroesophageal reflux disease?

Authors:  John E Pandolfino; Kumar Krishnan
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-28       Impact factor: 11.382

9.  Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.

Authors:  G Galindo; J Vassalle; S N Marcus; G Triadafilopoulos
Journal:  Dis Esophagus       Date:  2012-08-02       Impact factor: 3.429

10.  Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD.

Authors:  K C Trimble; A Pryde; R C Heading
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

View more
  3 in total

1.  Initial Experience of Endoscopic Radiofrequency Waves Delivery to the Lower Esophageal Sphincter (Stretta Procedure) on Symptomatic Gastroesophageal Reflux Disease Post-Sleeve Gastrectomy.

Authors:  Nesreen Khidir; Luigi Angrisani; Jowhara Al-Qahtani; Sheraz Abayazeed; Moataz Bashah
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

2.  Evaluations of life style factors and the severity of Gastroesophageal reflux disease; a case-control study.

Authors:  Saba Fakhrieh Asl; Fariborz Mansour-Ghanaei; Hooman Samadi; Farahnaz Joukar
Journal:  Int J Mol Epidemiol Genet       Date:  2015-09-09

3.  The Effect of Zinc Supplementationon the Symptoms of Gastroesophageal Reflux Disease; a Randomized Clinical Trial.

Authors:  Afshin Shafaghi; Jalal Hasanzadeh; Fariborz Mansour-Ghanaei; Farahnaz Joukar; Maryam Yaseri
Journal:  Middle East J Dig Dis       Date:  2016-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.